IGFBP2 and breast carcinoma: As shown in Figure 3, knockdown of IGFBP2 in BT474 breast cancer cells substantially decreased the expression of β-catenin in both the clones C5 and C12, suggesting a direct regulation of β-catenin by IGFBP2.